Faron Pharmaceuticals Oy (FARN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Faron Pharmaceuticals Oy (FARN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH207093D
  • |
  • Pages: 42
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the treatment of acute respiratory distress syndrome (ARDS) an orphan lung disease. Faron's drug platform traumakine prevents vascular leakage through the injured endothelium of several central organs. Its pipeline products concentrates on the therapeutic areas of acute organ traumas, cancer immunotherapy and vascular damage. The company also works in collaboration with academic institutions. Faron Pharma is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy (FARN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Medical Devices Deals, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deal Details

Partnerships

Faron Pharma Enters into Agreement with University of Birmingham Medical School

Faron Pharma Enters into Agreement with Selexis

Faron Pharma Enters into Joint Development Partnership with Turku PET Center

Licensing Agreements

Pharmbio Korea Enters into Licensing Agreement with Faron Pharma

China Medical System Enters into Licensing Agreement with Faron Pharma

Equity Offering

Faron Pharma Raises USD10 Million in Second Tranche of Private Placement of Shares

Faron Pharma Raises USD0.5 Million in Second Tranche of Rights Offering of Shares

Faron Pharma Raises USD11.9 Million in Private Placement of Shares

Faron Pharma Raises USD1.3 Million in Rights Offering of Shares

Faron Pharma to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants

Faron Pharma Raises USD0.3 Million in Private Placement of Shares

Faron Pharma Raises USD6 Million in Private Placement of Shares

Faron Pharma Raises USD10.4 Million in Private Placement of Shares

Faron Pharma Raises Funds in IPO

Acquisition

A&B Acquires 15.72% Stake in Faron Pharma for USD5.6 Million

Faron Pharmaceuticals Oy-Key Competitors

Faron Pharmaceuticals Oy-Key Employees

Faron Pharmaceuticals Oy-Locations And Subsidiaries

Head Office

Recent Developments

Financial Announcements

Sep 06, 2017: Faron Pharmaceuticals: Interim Results for the six months ended 30 June 2017

Mar 29, 2017: Faron Pharmaceuticals: Final Results for the year ended 31 December 2016

Feb 09, 2017: Faron update for 2017

Corporate Communications

Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer

Apr 19, 2017: Faron Pharmaceuticals: Proposed Board Changes

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Figures

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Medical Devices Deals, 2012 to YTD 2018

List of Tables

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Key Facts, 2016

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Deals By Therapy Area, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Medical Devices Deals, 2012 to YTD 2018

Faron Pharmaceuticals Oy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Faron Pharma Enters into Agreement with University of Birmingham Medical School

Faron Pharma Enters into Agreement with Selexis

Faron Pharma Enters into Joint Development Partnership with Turku PET Center

Pharmbio Korea Enters into Licensing Agreement with Faron Pharma

China Medical System Enters into Licensing Agreement with Faron Pharma

Faron Pharma Raises USD10 Million in Second Tranche of Private Placement of Shares

Faron Pharma Raises USD0.5 Million in Second Tranche of Rights Offering of Shares

Faron Pharma Raises USD11.9 Million in Private Placement of Shares

Faron Pharma Raises USD1.3 Million in Rights Offering of Shares

Faron Pharma to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants

Faron Pharma Raises USD0.3 Million in Private Placement of Shares

Faron Pharma Raises USD6 Million in Private Placement of Shares

Faron Pharma Raises USD10.4 Million in Private Placement of Shares

Faron Pharma Raises Funds in IPO

A&B Acquires 15.72% Stake in Faron Pharma for USD5.6 Million

Faron Pharmaceuticals Oy, Key Competitors

Faron Pharmaceuticals Oy, Key Employees

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 16863
Site License
USD 500 INR 33725
Corporate User License
USD 750 INR 50588

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com